Replies to post #6304 on BioSante Pharmaceuticals, Inc. (BPAX)

[PennyStockInvestor]

TooNiceStocks Initiates Coverage on BPAX BioSante


http://www.toonicestocks.com/news/2047-toonicestocks-initiates-coverage-biosante-pharmaceuticals-inc-nasdaq-bpax-looming-fda-deci


TooNiceStocks has uncovered multiple catalysts and corporate developments happening with the company. Often, biotech companies in our opinion have “all their eggs in one basket” and a failure of a late-stage drug is often detrimental to the shareholder value and financials as the development costs of running an additional trial or developing a new product from the beginning are lengthy and expensive endeavors. BioSante, on the other hand, has a fairly deep pipeline with one drug approved and another facing a regulatory decision in the form of a PDUFA on February 14th, 2012. TooNiceStocks also uncovered BioSante financials are also surprisingly strong for a development stage biotech company.

[nutsyprofessor]

Yeah, you keep it real buddy, oh, and make sure not to blink, otherwise you'll miss your chance to jump in when that notice comes out, lol.

[PennyStockInvestor]

The Nasdaq Delisting Process:

1. Deficiency Notice: If a company listed on the NCM fails to meet the minimum bid price requirement for a period of thirty consecutive trading days, it can expect to receive a deficiency notice from NASDAQ. The deficiency notice will identify the listing deficiency and will provide that the company has a period of 180 calendar days during which to regain compliance with the continued listing requirements. In order to regain compliance (if the deficiency is based on the failure to maintain the minimum bid price), the company’s closing bid price must be at or above $1.00 for a minimum of ten consecutive trading days during such period.

Click on the link below to read more -
http://www.mbbp.com/resources/business/nasdaq-delisting.html


According to this BPAX has 180 calendar days during which to regain compliance of the $1 price per share standard. After BPAX gets approval Feb. 14th this stock should be way above $1 in my opinion. They have 180 days to regain compliance. Now the truth is out. Don't let anyone scare you out of your shares of BPAX stock. Even if they do not meet the requirement they can receive a second 180 day grace period if the company has at least 1 million in market value of shares which i'm sure BPAX has. Read below for more info.

2. Additional Compliance Period for NCM Listed Companies: If a company listed on the NCM is unable to regain compliance with the $1.00 minimum bid price requirement within the initial 180 day period, it will receive a second 180 day grace period provided the company (a) has at least $1 million in market value of shares held by non-affiliates and satisfies all of the other listing requirements for initial listing on the NCM (except the bid price requirement) and (b) notifies NASDAQ of its intent to cure the listing deficiency. If it does not appear to NASDAQ that it is possible for the company to cure the deficiency, this second grace period will not be granted